3-Arm Randomized Placebo Controlled Double Blind Phase 3 Study to Evaluate Safety and Efficacy of Once-Daily and Twice-Daily Hydrocortisone Acetate 90 mg Suppository Administered With a Sephure Applicator in Subjects With Ulcerative Colitis
Latest Information Update: 26 Jun 2025
At a glance
- Drugs Hydrocortisone (Primary)
- Indications Ulcerative colitis
- Focus Registrational; Therapeutic Use
- Acronyms CESSA
- Sponsors Cristcot
Most Recent Events
- 26 Jun 2025 New trial record
- 10 Jun 2025 According to Cristcot Media Release, New Drug Application for Ulcerative Colitis on Track to be Filed in 2025.
- 10 Jun 2025 Results published in the Cristcot Media Release.